(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KMAP

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

KMAP

ST13

US500000079271477

Class

9, 35, 42

Filing

79271477

Registration

6138605

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

09/02/2025

Trademark type

Combined

Nice classes

9, 35, 42

Filing date

10/07/2019

Registration date

09/01/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/01/2020

Last transaction

09/02/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

03

Owner location

Seoul 03760, KR

Examiner

O'BRIEN, ELIZABETH

Law office

L50

Current location

TMEG LAW OFFICE 105

Holders and representatives

Holders

KAIPHARM CO., LTD.

Representatives

Lenny R. Jiang Paratus Law Group, PLLC

Technical classification

Nice Classes

Class 9Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Recorded computer software for creating searchable databases; Recorded computer software to enable searching of data; Recorded software for processing transcriptome and drug-treated cell growth profilesincluding digital images; Recorded software for analyzing drug mode of actions and proposing new indications; Recorded medical software for controlling and managing medical information

Class 35

Compilation of information into computer databases; systemization of information into computer databases

Class 42

Pharmaceutical research and development; scientific research for medical purposes; development of pharmaceutical preparations and medicines; biological research; biochemical research

Publications

History of USPTO decisions and trademark events.

31 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

09/01/2025

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

04/19/2023

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

03/05/2023

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

07/11/2022

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

07/05/2022

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

02/12/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/10/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/23/2020

FIMP

FINAL DISPOSITION PROCESSED

12/23/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/01/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

09/01/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/16/2020

PUBO

PUBLISHED FOR OPPOSITION

06/16/2020

GPNX

NOTIFICATION PROCESSED BY IB

06/12/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/27/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/27/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/27/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/06/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/27/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/27/2020

ALIE

ASSIGNED TO LIE

04/27/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/22/2020

RFNT

REFUSAL PROCESSED BY IB

02/28/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/11/2020

RFRR

REFUSAL PROCESSED BY MPU

02/11/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/16/2020

CNRT

NON-FINAL ACTION WRITTEN

01/15/2020

DOCK

ASSIGNED TO EXAMINER

01/10/2020

MAFR

APPLICATION FILING RECEIPT MAILED

11/19/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/14/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/07/2019

Continuous trademark protection

Get notified about every new filing that threatens KMAP or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.